NeuroVasc Clinical Inc. to supply FREMS to first clinic.

EKO International Corp – NeuroVasc Clinical Inc. tosupply FREMS to first clinic.

Burlington, Ontario

EKO is proud to announce that its JV partnership NeuroVascClinical Inc. has entered into an agreement with the prestigious MeyerInstitute in Hamilton Ontario to provide FREMS to its family of patients. TheMeyer Institute is one of Canada’s leaders in the treatment and management ofdiabetic wounds and limb care. Dr Perry Meyer MD is an International lectureron limb care and a proponent of research into new technologies to better servepatients and save limbs. FREMS provide an FDA and Health Canada approved clinicbased treatment that acts to increase vascularity and nerve function indiabetic patients who suffer from neuropathy. Dr Paul Ziemer President ofNeuroVasc Clinical has worked with the Meyer Institute in the past doingresearch into wound treatments. Neurovasc is in the process of completing theclinic installation which it anticipates will have 5 machines operating whenfully completed with a capacity to treat 50 patients a day. Further news willbe released as the clinic nears completion in the next month.

This press release contains forward-looking statements thatreflect the Company's current expectation regarding future events. Actualevents could differ materially and substantially from those projected herein anddepend on a number of factors. Certain statements in this release, and otherwritten or oral statements made by Eko International (“The Company”) are"forward-looking statements" within the meaning of Section 27A of theSecurities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.You should not place undue reliance on forward-looking statements since theyinvolve known and unknown risks, uncertainties and other factors, which are, insome cases, beyond the Company's control and which could, and likely will,materially affect actual results, levels of activity, performance orachievements. The Company assumes no obligation to publicly update or revisethese forward-looking statements for any reason, or to update the reasonsactual results could differ materially from those anticipated in theseforward-looking statements, even if new information becomes available in thefuture. Important factors that could cause actual results to differ materiallyfrom the company's expectations include, but are not limited to, those factorsthat are disclosed under the heading "Risk Factors" and elsewhere indocuments filed by the company from time to time with the United StatesSecurities and Exchange Commission and other regulatory authorities.

To contact the company by e-mail, please use info@ekointernational.com